The biggest integrated demonstration charging station, combining solar power generation, energy storage, charging and testing, recently started operating in Taizhou.

Overseas Pharmaceutical (Taizhou), located in China Medical City, strives to make its sustained-release preparations and controlled release preparations increasingly go global.

The Taizhou Medical City Biomedical Pilot Platform was included in the first group of national key cultivation pilot platforms.

Cellularforce, a leading one-stop service provider for Contract Development and Manufacturing Organization outsourcing manufacturing of antibody drugs in China, is on the move.

A new nutrition and intelligent health foods manufacturing base that is being operated by Jiangsu Beevip Biotechnology, started operating on April 7.

Taizhou has moved to further boost its cooperation with the world's leading intergovernmental organization for research, training and technology transfer.

The Jie Tai Si sugar chain detection kit developed by Jiangsu SysDiagno Biotech was included in the 2024 Medical Device Registration Work Report.

Developed by Jiangsu Cowin Biotech, located in the Taizhou Medical High-tech Zone, a landmark cancer detection kit was recently approved for sale.